Multicenter Prospective Non-randomized Controlled Study of Ella Photodynamic Therapy for Cervical HSIL/CIN2 | MicrobiomeTrials← Back to trialsNCT07306260
Multicenter Prospective Non-randomized Controlled Study of Ella Photodynamic Therapy for Cervical HSIL/CIN2
RecruitingNAINTERVENTIONAL
Trial Details
Start: 2026-01-29Est. Completion: 2027-12
Enrollment target: 560 participants Locations- Women's Hospital School Of Medicine Zhejiang University, Hangzhou, Zhejiang, China
- First People's Hospital of Hangzhou, Hangzhou, Zhejiang, China
- Hangzhou Linping District first People's Hospital, Hangzhou, Zhejiang, China
- First Affiliated Hospital of Ningbo University, Ningbo, Zhejiang, China
- Shaoxing People's Hospital, Shaoxing, Zhejiang, China
Other microbiome trials you might be interested in
HSIL, High Grade Squamous Intraepithelial LesionDNA MethylationCIN - Cervical Intraepithelial Neoplasia
The goal of this observational study (retrospective cohort study) is to determine whether DNA methylation status in arch…
Lund, SwedenEst. completion Jun 2027
Vulvar HSILHPV
Problem description:
Yearly, approximately 45000 women develop vulvar cancer worldwide. It is estimated that about 30% …
Rotterdam, NetherlandsEst. completion Dec 1, 2028